Inflammatory bowel disease and osteoporosis

被引:0
|
作者
Ljunghall, S [1 ]
Ljunggren, Ö [1 ]
机构
[1] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
来源
ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 1999年 / 31卷 / 02期
关键词
bone mineral density; corticosteroids; inflammatory bowel disease; osteoporosis;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with inflammatory bowel disease are at increased risk to develop osteoporosis due to the underlying inflammatory process, as a result of the intestinal dysfunction and as a consequence of the treatment given to counteract the disease. Furthermore, patients with inflammatory bowel disease presumably share with the general population other common risk factors for osteoporosis, e.g. heredity, smoking, inactivity and hormone deficiency. Most recent investigations demonstrate a reduced bone mineral density in inflammatory bowel disease patients, often more apparent in the femoral neck than in the lumbar spine, but there are no controlled fracture studies in these patients. There is , at the bone tissue level, evidence for a negative remodelling balance, i.e., increased resorption with or without suppressed formation and it is commonly found that corticosteroid use significantly contributes to bone loss. Although controlled studies are few, patients with inflammatory bowel disease should be informed about osteoporosis, have their bone mineral density measured and receive general advice including hormone replacement therapy, calcium and vitamin D. In more severe cases antiresorptive therapy might be instituted under close supervision.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [41] Therapy Insight: osteoporosis in inflammatory bowel disease—advances and retreats
    Charles N Bernstein
    William D Leslie
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 232 - 239
  • [42] Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease
    Silvennoinen, JA
    Lehtola, JK
    Niemela, SE
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) : 367 - 371
  • [43] Osteoporosis in patients with inflammatory bowel disease -: prevalence and risk factors
    Tirpitz, C
    Pischulti, G
    Klaus, J
    Rieber, A
    Brückel, J
    Böhm, BO
    Adler, G
    Reinshagen, M
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1999, 37 (01): : 5 - 12
  • [44] Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease
    Adriani, A.
    Pantaleoni, S.
    Luchino, M.
    Ribaldone, D. G.
    Reggiani, S.
    Sapone, N.
    Sguazzini, C.
    Isaia, G.
    Pellicano, R.
    Astegiano, M.
    PANMINERVA MEDICA, 2014, 56 (02) : 145 - 149
  • [45] The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease
    Miznerova, E.
    Hlavaty, T.
    Koller, T.
    Toth, J.
    Holociova, K.
    Huorka, M.
    Killinger, Z.
    Payer, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2013, 114 (08): : 439 - 445
  • [46] Effects of emodin on inflammatory bowel disease-related osteoporosis
    Luo, Jing-sheng
    Zhao, Xinhua
    Yang, Yu
    BIOSCIENCE REPORTS, 2020, 40
  • [47] Physician awareness and management of osteoporosis in patients with inflammatory bowel disease
    Sharma, AK
    Infantolino, A
    Choudhary, C
    Goldstein, F
    Sandorfi, N
    DiMarino, AJ
    Cohen, S
    GASTROENTEROLOGY, 2004, 126 (04) : A437 - A437
  • [48] IDENTIFYING PREDICTORS OF OSTEOPOROSIS SCREENING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Rau, Sameeha
    Roney, Andrew R.
    Fansiwala, Kush M.
    Spartz, Ellen J.
    Kim, Sowon
    Bonthala, Nirupama
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2024, 166 (05) : S659 - S660
  • [49] Corticosteroid-induced osteoporosis and osteopenia in inflammatory bowel disease
    Firouzi, F
    Zali, MR
    Bahari, A
    Daryani, NE
    Aghazadeh, R
    Emam, MM
    Shalmani, HM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S309 - S309
  • [50] Therapy Insight: osteoporosis in inflammatory bowel disease - advances and retreats
    Bernstein, CN
    Leslie, WD
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (05): : 232 - 239